A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis

被引:23
作者
Wilkins, Mark R. [1 ]
Khan, Sharmina [1 ]
Bunce, Catey [1 ]
Khawaja, Anthony [1 ]
Siriwardena, Dilani [1 ]
Larkin, Daniel F. P. [1 ]
机构
[1] Moorfields Eye Hosp, London EC1V 2PD, England
关键词
EPIDEMIC KERATOCONJUNCTIVITIS; ADENOVIRAL CONJUNCTIVITIS; ARTIFICIAL TEARS; INTERFERON; INFECTION; THERAPY;
D O I
10.1136/bjo.2010.188623
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Aims To assess whether topical steroids improve patient comfort compared with hypromellose in acute presumed viral conjunctivitis. Methods Patients presenting with acute follicular conjunctivitis, presumed viral in origin, were randomised to receive either dexamethasone 0.1% or hypromellose 0.3% drops four times daily for 1 week. At review after 5-7 days patients completed questionnaires on whether they thought the treatment had helped and on their level of discomfort. A physician assessed conjunctival hyperaemia using a grading scale. Results 111 patients were randomised: 56 received dexamethasone drops and 55 received hypromellose lubricant drops. Eighty-eight returned for review. Most patients (39/45 (87%)) receiving dexamethasone and most of those receiving hypromellose 30/43 (70%) felt that the treatment helped. Analysis of all responses showed a significant difference between treatments (p = 0.0248, rank sum test). No significant differences between dexamethasone and hypromellose arms were found in the patients' perceived level of discomfort or the physician grading of conjunctival hyperaemia. No patient experienced a serious complication. Conclusions There us now evidence to support the use of a short course of topical dexamethasone for patients presenting with acute follicular conjunctivitis presumed to be viral in origin. Where topical dexamethasone is prescribed we have not found it to be harmful.
引用
收藏
页码:1299 / 1303
页数:5
相关论文
共 25 条
  • [1] INTERFERON TREATMENT OF ADENOVIRAL CONJUNCTIVITIS
    ADAMS, CP
    COHEN, EJ
    ALBRECHT, J
    LAIBSON, PR
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1984, 98 (04) : 429 - 432
  • [2] TREATMENT OF ADENOVIRUS INFECTION OF EYE WITH 5-10DO-2'-DEOXYURIDINE - A DOUBLE-BLIND TRIAL
    DUDGEON, J
    BHARGAVA, SK
    ROSS, CAC
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1969, 53 (08) : 530 - &
  • [3] Validation of grading scales for contact lens complications
    Efron, N
    Morgan, PB
    Katsara, SS
    [J]. OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2001, 21 (01) : 17 - 29
  • [4] Elnifro EM, 2000, INVEST OPHTH VIS SCI, V41, P1818
  • [5] EVERITT H, 2003, EVIDENCE BASED OPHTH
  • [6] Rapid and quantitative detection of human adenovirus DNA by real-time PCR
    Heim, A
    Ebnet, C
    Harste, G
    Pring-Åkerblom, P
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (02) : 228 - 239
  • [7] The effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis -: A controlled clinical pilot study
    Hillenkamp, J
    Reinhard, T
    Ross, RS
    Böhringer, D
    Cartsburg, O
    Roggendorf, M
    De Clercq, E
    Godehardt, E
    Sundmacher, R
    [J]. OPHTHALMOLOGY, 2002, 109 (05) : 845 - 850
  • [8] INAGAWA WS, 1999, GRAEFES ARCH CLIN EX, V237, P35
  • [9] Infectious Agents Surveillance Center of Japan, 1995, INFECT AGENTS SURVEI, V16, P97
  • [10] COMPARATIVE-STUDIES ON ETIOLOGY AND EPIDEMIOLOGY OF VIRAL CONJUNCTIVITIS IN 3 COUNTRIES OF EAST-ASIA - JAPAN, TAIWAN AND SOUTH-KOREA
    ISHII, K
    NAKAZONO, N
    FUJINAGA, K
    FUJII, S
    KATO, M
    OHTSUKA, H
    AOKI, K
    CHEN, CW
    LIN, CC
    SHEU, MM
    LIN, KH
    OUM, BS
    LEE, SH
    CHUN, CH
    YOSHII, T
    YAMAZAKI, S
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1987, 16 (01) : 98 - 103